Navigation Links
Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
Date:8/19/2008

Fraxel re:pair(R) system receives Health Canada clearance to treat severe

sun damage, sagging skin, vascular dyschromia and wrinkles

MOUNTAIN VIEW, Calif., Aug. 19 /PRNewswire/ -- Reliant Technologies, Inc., the pioneer of fractional resurfacing and market leader of aesthetic laser skin treatments, today announced its Canadian launch of the Fraxel re:pair laser system with the recent Health Canada Clearance. The Canadian debut of the Fraxel re:pair system occurred at the recent Controversies and Conversations in Laser Cosmetic Surgery symposium in Whistler, B.C., Canada.

The Fraxel re:pair system is now available for purchase by dermatologists, plastic surgeons and cosmetic physicians in Canada. In December 2007, the Fraxel re:pair system received the industry's first FDA 510(K) clearance for a fractional ablative laser system for treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions and vascular dyschromia.

The industry's first minimally invasive, ablative fractional laser system, the Fraxel re:pair laser delivers a full spectrum of aesthetic treatment from mild to aggressive. It is the only ablative resurfacing device capable of being operated by a single clinician because of its built-in smoke evacuation system, and capable of treating at depths from 110 micrometers (um) to 1.6 mm into the dermis.

"Ablative fractional skin resurfacing with the Fraxel re:pair laser is a major breakthrough for my patients who desire significant tissue tightening, wrinkle reduction, and improvement in skin quality, both on and off the face," said William McGillivray, MD, a director of Pacific Dermaesthetics in Vancouver, B.C.

Mark Lupin, MD, FRCPC, director of Cosmedica in Victoria, B.C., added, "The Fraxel re:pair system addresses the full range of photodamage - wrinkles, lines, pigment, and vascular irregularities, all in a single treatment."

The Fraxel re:pair laser system, the res
'/>"/>

SOURCE Reliant Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
2. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
3. RainDance Technologies Appoints Olex Vice President, System Development
4. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
5. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
6. ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
7. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
8. MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
9. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
10. [video] Edward Spink, CEO of TurboSonic Technologies, Inc. Discusses Contract With Biofuel Producer in Exclusive Interview on WallSt.nets 3-Minute Press Show
11. Local officials move toward monitoring nanotechnologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)...  Neurotech Pharmaceuticals, Inc., announced today the first ... 2 clinical trial of NT-503 Encapsulated Cell Therapy ... choroidal neovascularization secondary to age related macular degeneration ... growth factor (VEGF) receptor protein continuously produced by ... proof-of-concept study will evaluate NT-503 ECT as a ...
(Date:9/2/2015)... ZIONA, Israel , September 2, 2015 /PRNewswire/ ... today announced the intent of the National Institute of Allergy ... of Health (NIH) within the Department of Health and Human ... be held in the United States ... of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as a ...
(Date:9/2/2015)... ... 02, 2015 , ... The TS5-Q is designed for myriad ... to analysis of athletic performance. Producing high-resolution slow-motion video , the TS5-Q ... process with the naked eye. , Slow motion sequences are commonly seen ...
(Date:9/1/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... Annual Global Investment Conference sponsored by H.C. Wainwright ... The St. Regis Hotel in New York, ... , Chief Executive Officer, will provide an overview of ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... 19 DuPont Chairman and,CEO Charles O. Holliday, Jr., ... will enable the world to keep pace with the ... materials. "Biotechnology is the most powerful tool available ... said. "It holds the promise,to deliver the world more, ...
... Oct. 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ... specialty pharmaceutical and,medical device company, today announced ... September 30, 2007 and updated its financial,outlook ... 2007, in conjunction with the,release of Boston ...
... Ltd (SWX: ATLN) today,announced multiple presentations regarding ... the efficacy and safety of Tracleer in,combination ... first 1,500,patients with pulmonary arterial hypertension (PAH) ... And Long-term PAH Disease,Management) Registry. The presentations ...
Cached Biology Technology:Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize 2Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 2Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 3Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 4Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 5Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 6Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 7Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 8Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 9Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 10Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 11Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007 2Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007 3
(Date:8/26/2015)... PUNE, India , August 26, 2015 ... (Two, Three, Four, and Five Factor), Application (Travel & ... and Geography - Global Forecast to 2020", published by ... 9.60 Billion by 2020, growing at a CAGR of ... 71 Tables and 82 F igures spread through ...
(Date:8/20/2015)... , Aug. 20, 2015 The ... consumers that are active and healthy. However, wearable ... the hospital environment to help improve diagnostic capabilities ... video from the Wearable Technologies Conference 2015 ... new applications for wearables in healthcare.    ...
(Date:8/18/2015)... Aug. 18, 2015  Navitas today announced ... to the Submission Content Management webinar scheduled ... non-profit forum. Dedicated to the Implementation of Regulatory ... platform for industry, vendors, health authorities, consultants ... work towards a standard method of implementing ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3
... been studying the rare and threatened bonobo ape will lead monitoring ... wild in the Congo for the first time this month. ... group of 18 orphan bonobos will be returned to the wild. ... the bonobos as they adjust to life back in the wild," ...
... States must be careful that the new emphasis on ... into account potential damage to the nation,s water resources. ... have far-reaching environmental and economic repercussions, and it will ... and water security," said a report titled "The Water ...
... microtubules might be responsible for some cases of the neurological ... June 15, 2009 issue of the Journal of Cell ... microtubules too stable to perform their jobs, the researchers find. ... their strength, or both. One of these mutations leads to ...
Cached Biology News:Duke, Harvard researchers to monitor bonobo reintroduction 2Rice University researchers ask if biofuels will lead to a 'drink or drive' 2